Elevance Health Inc (MEX:ELV)
MXN 7,144.06 (0%) Market Cap: 1.58 Tn Enterprise Value: 1.97 Tn PE Ratio: 17.88 PB Ratio: 2.08 GF Score: 75/100

Elevance Health Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2024 / 01:30PM GMT
Release Date Price: MXN8442.11
Andrew Mok

Hi. Good morning, and welcome back to Day 3 of the Barclay's Global Healthcare Conference. My name is Andrew Mok, I'm the Managed Care and Facilities Analyst here at Barclays. And with me, I'm pleased to welcome Mark Kaye, CEO ((sic) [CFO]; Pete Haytaian, EVP and President of CarelonRX and Carelon; and Steve Tanal, Vice President of Investor Relations. Gentlemen, welcome.

Mark Bradley Kaye
Elevance Health, Inc. - Executive VP & CFO

Thanks, Andrew. Thanks for having us.

Questions & Answers

Andrew Mok

So maybe to start, there's been a wide range of expectations laid out so far this year with respect to 2024 utilization, particularly within the Medicare business. Mark, it's always nice to hear from someone who has a fresh set of eyes to the business, it's especially helpful if that person is an actuary. So from your perspective, what's causing so much dispersion across the industry right now?

Mark Bradley Kaye
Elevance Health, Inc. - Executive VP & CFO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot